secwatch.observer — SEC 8-K summary
======================================

Issuer:     MESA LABORATORIES INC /CO/ (MLAB)
CIK:        0000724004
Form:       8-K
Filed at:   2024-02-05T23:59:59+00:00
Accession:  0001437749-24-003052
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mesa Labs Q3 revenue down 1.5%; operating loss of $67K; core organic revenue declines 9%
--------------------------------------------------------------------------------

- Revenue $53.5M, down 1.5% YoY; core organic revenue declined 9%.
- Operating loss of $67K vs income $3.2M prior year; net income $2.1M up 369% on unusual items.
- Non-GAAP adjusted operating income excl. unusual items $12.0M, down 6.8% YoY but up 7.3% sequentially.
- Clinical Genomics down 19% on China anti-corruption; Biopharm capital constrained but consumables +16.5%.
- Calibration Solutions revenue +12.9%, gross margin +600 bps; GKE acquisition added $3.8M revenue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/724004/000143774924003052/0001437749-24-003052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/724004/000143774924003052/mlab20240202_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-003052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer